Japan Bioventure Dnavec To Begin Marketing iPS Kit Abroad
This article was originally published in PharmAsia News
Executive Summary
Japanese bioventure Dnavec said it plans to launch its kit for making pluripotent stem cells elsewhere in Asia as well as in Europe and the United States